Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics


Tandem Diabetes Care, Inc. (TNDM): $117.69

-3.46 (-2.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TNDM POWR Grades


  • Growth is the dimension where TNDM ranks best; there it ranks ahead of 90.82% of US stocks.
  • The strongest trend for TNDM is in Momentum, which has been heading down over the past 48 weeks.
  • TNDM's current lowest rank is in the Momentum metric (where it is better than 15.33% of US stocks).

TNDM Stock Summary

  • With a price/earnings ratio of 1,206.46, Tandem Diabetes Care Inc P/E ratio is greater than that of about 99.48% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Tandem Diabetes Care Inc is higher than 95.03% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 13.08, Tandem Diabetes Care Inc has a higher such ratio than 86.02% of stocks in our set.
  • Stocks that are quantitatively similar to TNDM, based on their financial statements, market capitalization, and price volatility, are BLFS, PEGA, ZI, PCTY, and MLAB.
  • Visit TNDM's SEC page to see the company's official filings. To visit the company's web site, go to www.tandemdiabetes.com.

TNDM Valuation Summary

  • In comparison to the median Healthcare stock, TNDM's price/earnings ratio is 2854.52% higher, now standing at 1078.4.
  • Over the past 93 months, TNDM's price/sales ratio has gone down 8.7.
  • TNDM's price/sales ratio has moved down 8.7 over the prior 93 months.

Below are key valuation metrics over time for TNDM.

Stock Date P/S P/B P/E EV/EBIT
TNDM 2021-08-31 11.7 20.4 1078.4 379.2
TNDM 2021-08-30 11.7 20.5 1079.6 379.6
TNDM 2021-08-27 11.5 20.1 1060.5 373.1
TNDM 2021-08-26 11.6 20.3 1070.2 376.4
TNDM 2021-08-25 11.6 20.3 1071.9 377.0
TNDM 2021-08-24 11.7 20.5 1081.7 380.3

TNDM Growth Metrics

  • The 5 year price growth rate now stands at 4.02%.
  • The year over year revenue growth rate now stands at 37.47%.
  • Its 2 year cash and equivalents growth rate is now at 19.02%.
Over the past 18 months, TNDM's revenue has gone up $242,539,000.

The table below shows TNDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 604.844 87.381 6.556
2021-03-31 541.941 73.985 -24.559
2020-12-31 498.83 24.669 -34.382
2020-09-30 439.163 28.874 -48.73
2020-06-30 410.217 37.329 -42.223
2020-03-31 394.236 25.398 -16.628

TNDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TNDM has a Quality Grade of C, ranking ahead of 64.6% of graded US stocks.
  • TNDM's asset turnover comes in at 0.823 -- ranking 37th of 183 Medical Equipment stocks.
  • MLSS, CUTR, and TFX are the stocks whose asset turnover ratios are most correlated with TNDM.

The table below shows TNDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.823 0.532 0.024
2021-03-31 0.785 0.523 -0.018
2020-12-31 0.849 0.522 -0.045
2020-09-30 0.897 0.524 -0.109
2020-06-30 1.040 0.526 -0.154
2020-03-31 1.296 0.536 -0.091

TNDM Price Target

For more insight on analysts targets of TNDM, see our TNDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.75 Average Broker Recommendation 1.62 (Moderate Buy)

TNDM Stock Price Chart Interactive Chart >

Price chart for TNDM

TNDM Price/Volume Stats

Current price $117.69 52-week high $130.73
Prev. close $121.15 52-week low $76.19
Day low $116.01 Volume 229,890
Day high $120.00 Avg. volume 711,044
50-day MA $112.92 Dividend yield N/A
200-day MA $96.95 Market Cap 7.42B

Tandem Diabetes Care, Inc. (TNDM) Company Bio


Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.


TNDM Latest News Stream


Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream


Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about Tandem Diabetes Care Inc that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

Kilroy signs three new leases totalling 330,000 sq ft off office-to-life-science redevelopments in San Diego

Kilroy signs three new leases totalling 330,000 sq ft off office-to-life-science redevelopments in San Diego Submitted 21/09/2021 - 10:01am Kilroy Realty Corporation (Kilroy) has signed three new leases totalling 330,000 square feet with publicly traded life science and biotech companies in San Diego. Tandem Diabetes Care (~182,000 sq ft), DermTech (~96,000 sq ft), and Sorrento Therapeutics (~52,000 sq ft) lease transactions involve the redevelopment of commercial office space into three state-of-the-art life science/lab facilities and support Kilroy''s significant investment in broadening its life science portfolio. Kilroy also plans for a ~600,000 sq ft project (Santa Fe Summit) with tech office/life science flexibility on the 56 Corridor to meet the growing demand for space among lif...

PropertyFundsWorld | September 21, 2021

Here's Why Tandem Diabetes Care, Inc. (TNDM) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | September 15, 2021

Tandem Diabetes (TNDM) Rides on Innovation Despite Cost Woes

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 insulin pumps by both new and existing users is encouraging.

Yahoo | September 14, 2021

Insider Of Tandem Diabetes Care Trades $733.89 Thousand In Company Stock

James Leal , Insider at Tandem Diabetes Care (NASDAQ: TNDM ), made a large buy and sell of company shares on September 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 7, James Leal bought 3,574 Tandem Diabetes Care shares at a price of $82.34 per share, for a total of $294,283. They then sold their shares on the same day in the open market at a price of $123.00 to raise a total of $439,602 from the sale. Leal still owns a total of 3,751 of Tandem Full story available on Benzinga.com

Benzinga | September 9, 2021

The Daily Biotech Pulse: MacroGenics'' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA''s FDA Nod

Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Candel Therapeutics, Inc. (NASDAQ: CADL ) (announced completion of patient enrollment in the pivotal phase 3 study of CAN-2409 in prostate cancer) Cardiol Therapeutics Inc. (NASDAQ: CRDL ) (announced addition to its board) Caribou Biosciences, Inc. (NASDAQ: CRBU ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Edwards Lifesciences Corporation (NYSE: EW ) Er...

Benzinga | September 8, 2021

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo 6.69%
3-mo 20.83%
6-mo 34.30%
1-year 6.52%
3-year 174.72%
5-year 59.69%
YTD 23.00%
2020 60.51%
2019 56.99%
2018 1,508.90%
2017 -89.02%
2016 -81.80%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 3.7273 seconds.